Diagnosis of hyperadrenocorticism in dogs: A survey of internists and dermatologists

Journal of the American Veterinary Medical Association

Volumn 220, Issue 11, 2002, Pages 1643-1649

  Behrend, Ellen N ^c   Kemppainen, Robert J ^e   Clark, Terrence P ^d   Salman, M D ^a   Peterson, Mark E ^b  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b ANIMAL MEDICAL CENTER   (United States)

^c AUBURN UNIVERSITY   (United States)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; MACROGOL;

ARTICLE; CLINICAL PROTOCOL; DERMATOLOGY; DOG; ECHOGRAPHY; HYPERADRENOCORTICISM; INTERNAL MEDICINE; NONHUMAN; PROVOCATION TEST; QUESTIONNAIRE; SCREENING TEST;

CANIS FAMILIARIS;

EID: 0036605645     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2002.220.1643     Document Type: Article

References (45)

1. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism
2. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs
3. Plasma cortisol response to exogenous ACTH in 22 dogs with hyperadrenocorticism caused by adrenocortical neoplasia
4. Evaluation of the hypothalamic pituitary-adrenal axis in clinically stressed dogs
5. Evaluation of a combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism
6. Changes in adrenal cortisol secretion as reflected in the urinary cortisol/creatinine ratio in dogs
7. Urinary corticoids in the diagnosis of canine hyperadrenocorticism
8. Evaluation of the urinary cortisol:creatinine ratio in the diagnosis of hyperadrenocorticism in dogs
9. Urinary corticoid/creatinine ratios in the differentiation between pituitary-dependent hyperadrenocorticism and hyperadrenocorticism due to adrenocortical tumor in the dog
10. Evaluation of a urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs
11. Urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs
12. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs
13. Preservative effect of aprotinin on canine plasma immunoreactive adrenocorticotropin concentrations
14. Canine hyperadrenocorticism due to adrenocortical neoplasia
15. Treatment of hyperadrenocorticism in dogs: A survey of internists and dermatologists
16. Canine hyperadrenocorticism: Pretreatment clinical and laboratory evaluation of 117 cases
17. Diagnosis and medical management of canine Cushing's syndrome: A study of 57 consecutive cases
18. Assessment of two tests for the diagnosis of canine hyperadrenocorticism
19. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism
20. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression test with necropsy findings in dogs: 81 Cases (1985-1995)
21. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: Four cases (1983-1988)
22. Magnetic resonance imaging of the brain in dogs with recently diagnosed but untreated pituitary-dependent hyperadrenocorticism
23. Magnetic resonance imaging for diagnosis of pituitary macrotumors in dogs
24. Pituitary tumor size, neurologic signs, and relation to endocrine test results in dogs with pituitary-dependent hyperadrenocorticism: 43 Cases (1980-1990)
25. Evaluation of a six-hour combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism
26. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 Cases (1978-1995)
27. The synthetic ACTH stimulation test and measurement of endogenous plasma ACTH levels: Useful diagnostic indicators for adrenal disease in dogs
28. Effect of functional adrenocortical tumors on plasma cortisol and corticotropin concentrations in dogs
29. Diagnostic evaluation of canine serum alkaline phosphatase by immunochemical means and interpretation of results
30. Simple quantitative assay for canine steroid-induced alkaline phosphatase
31. Isoenzymes of canine plasma alkaline phosphatase: An investigation using isoelectric focusing and related to diagnosis
32. Diagnostic value of canine serum alkaline phosphatase and alkaline phosphatase isoenzymes
33. Diagnostic value of steroidinduced isoenzyme of alkaline phosphatase in the dog
34. The measurement of canine steroid-induced alkaline phosphatase by L-phenylalanine inhibition
35. Assessment of corticosteroid-induced isoenzyme as a screening test for hyperadrenocorticism in dogs
36. Source of serum alkaline phosphatase in clinically normal and diseased dogs: A clinical study
37. Diagnostic value of alkaline phosphatase isoenzyme separation by affinity electrophoresis in the dog
38. Corticosteroidinduced alkaline phosphatase isoenzyme in the diagnosis of canine hypercorticism
39. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms
40. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs
41. Mitotane (o,p′-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism
42. Diagnosis of canine hyperadrenocorticism
43. Computed tomographic characteristics of primary brain tumors in 50 dogs
44. Computed tomography in the diagnosis of canine hyperadrenocorticism not suppressible by dexamethasone
45. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogswith pituitary-dependent hyperadrenocorticism